Clinical Trial Update: A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of Tolvaptan tablets in patients with hypovolemic hyponatremia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia

Drugs mentioned

• Tolvaptan (Samsca) (tolvaptan)

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Hypovolemic Hyponatremia | Phase 2 | Status: COMPLETED